Heritage Investors Management Corp Has $16.71 Million Stock Position in IQVIA Holdings Inc. (NYSE:IQV)

Heritage Investors Management Corp raised its stake in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 8.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 94,795 shares of the medical research company's stock after buying an additional 7,051 shares during the quarter. Heritage Investors Management Corp owned about 0.05% of IQVIA worth $16,712,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Vanguard Group Inc. increased its position in shares of IQVIA by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 20,131,734 shares of the medical research company's stock valued at $3,956,087,000 after buying an additional 105,504 shares in the last quarter. Canada Pension Plan Investment Board grew its stake in IQVIA by 20.0% in the fourth quarter. Canada Pension Plan Investment Board now owns 4,282,024 shares of the medical research company's stock valued at $841,461,000 after acquiring an additional 712,958 shares during the period. Geode Capital Management LLC increased its holdings in shares of IQVIA by 1.9% in the fourth quarter. Geode Capital Management LLC now owns 4,175,524 shares of the medical research company's stock worth $818,315,000 after acquiring an additional 77,981 shares in the last quarter. Invesco Ltd. raised its position in shares of IQVIA by 53.4% during the fourth quarter. Invesco Ltd. now owns 2,590,260 shares of the medical research company's stock worth $509,012,000 after purchasing an additional 902,226 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in shares of IQVIA by 2.5% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,438,726 shares of the medical research company's stock valued at $481,380,000 after purchasing an additional 59,426 shares in the last quarter. 89.62% of the stock is owned by institutional investors.

IQVIA Stock Down 1.5%

IQV traded down $2.37 during trading on Friday, reaching $160.88. 2,312,787 shares of the stock were exchanged, compared to its average volume of 1,678,075. The company has a debt-to-equity ratio of 2.19, a quick ratio of 0.82 and a current ratio of 0.82. The stock's 50 day moving average price is $152.90 and its two-hundred day moving average price is $170.67. IQVIA Holdings Inc. has a twelve month low of $134.65 and a twelve month high of $252.88. The stock has a market cap of $27.83 billion, a P/E ratio of 21.92, a price-to-earnings-growth ratio of 1.78 and a beta of 1.30.

IQVIA (NYSE:IQV - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The medical research company reported $2.70 earnings per share for the quarter, topping the consensus estimate of $2.63 by $0.07. IQVIA had a net margin of 8.61% and a return on equity of 29.16%. The company had revenue of $3.83 billion for the quarter, compared to analyst estimates of $3.77 billion. During the same period in the previous year, the business earned $2.54 EPS. IQVIA's revenue for the quarter was up 2.5% compared to the same quarter last year. Equities analysts expect that IQVIA Holdings Inc. will post 10.84 EPS for the current year.

Analyst Ratings Changes

Several analysts have commented on IQV shares. JPMorgan Chase & Co. dropped their target price on shares of IQVIA from $232.00 to $177.00 and set an "overweight" rating on the stock in a report on Monday, May 19th. UBS Group lowered their price objective on shares of IQVIA from $255.00 to $185.00 and set a "buy" rating for the company in a research report on Wednesday, May 7th. Mizuho dropped their price objective on shares of IQVIA from $210.00 to $190.00 and set an "outperform" rating on the stock in a report on Thursday, May 15th. Evercore ISI upped their target price on shares of IQVIA from $170.00 to $180.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 9th. Finally, Truist Financial lowered their target price on IQVIA from $263.00 to $216.00 and set a "buy" rating for the company in a report on Thursday, April 10th. Eight research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $222.45.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.